Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator FDX1 in Clear Cell Renal Cell Carcinoma. | Genes (Basel) | 2022 | 36292610 | PubTator, text mining | PubMed |
| Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis. | Biomolecules | 2022 | 36291728 | PubTator, text mining | PubMed |
| Crystal Structure of the Human Copper Chaperone ATOX1 Bound to Zinc Ion. | Biomolecules | 2022 | 36291703 | PubTator, text mining | PubMed |
| Cisplatin Resistance: Genetic and Epigenetic Factors Involved. | Biomolecules | 2022 | 36291573 | PubTator, text mining | PubMed |
| Emerging Role of Non-Coding RNAs in Aortic Dissection. | Biomolecules | 2022 | 36291545 | PubTator, text mining | PubMed |
| Cancer cells hijack RNA processing to rewrite the message. | Biochem Soc Trans | 2022 | 36282006 | PubTator, text mining | PubMed |
| Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. | Front Oncol | 2022 | 36276096 | PubTator, text mining | PubMed |
| Cuproptosis patterns in papillary renal cell carcinoma are characterized by distinct tumor microenvironment infiltration landscapes. | Front Mol Biosci | 2022 | 36275614 | PubTator, text mining | PubMed |
| The cuproptosis-related gene signature serves as a potential prognostic predictor for ovarian cancer using bioinformatics analysis. | Ann Transl Med | 2022 | 36267774 | PubTator, text mining | PubMed |
| Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma. | Front Pharmacol | 2022 | 36267281 | PubTator, text mining | PubMed |
| Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis. | Front Genet | 2022 | 36263417 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance. | Front Pharmacol | 2022 | 36263125 | PubTator, text mining | PubMed |
| Bioinformatics analysis identified immune infiltration, risk and drug prediction models of copper-induced death genes involved in salivary glands damage of primary Sjögren's syndrome. | Medicine (Baltimore) | 2022 | 36254059 | PubTator, text mining | PubMed |
| RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer. | Adv Drug Deliv Rev | 2022 | 36252617 | PubTator, text mining | PubMed |
| A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy. | Front Mol Biosci | 2022 | 36250008 | PubTator, text mining | PubMed |
| A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer. | Front Immunol | 2022 | 36248908 | PubTator, text mining | PubMed |
| Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma. | Front Immunol | 2022 | 36248822 | PubTator, text mining | PubMed |
| The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy. | Oxid Med Cell Longev | 2022 | 36238639 | PubTator, text mining | PubMed |
| Novel genes and variants associated with congenital pituitary hormone deficiency in the era of next-generation sequencing. | Front Endocrinol (Lausanne) | 2022 | 36237189 | PubTator, text mining | PubMed |
| Metallo-Drugs in Cancer Therapy: Past, Present and Future. | Molecules | 2022 | 36235023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=36